Pleiotropic effects of statins in atherosclerotic disease

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 9, 2010, Pages 1235-1237

  Pasterkamp, Gerard ^a   Van Lammeren, Guus W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

cardiovascular disease; inflammation; plaque composition; statins

Indexed keywords

ATORVASTATIN; COLESTYRAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; SITOSTEROL;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE COMPARISON; HUMAN; HYPERCHOLESTEROLEMIA; MORBIDITY; MORTALITY; NOTE; PLEIOTROPY; PROPHYLAXIS;

EID: 77956497988     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.107     Document Type: Note

References (17)

1. No authors listed. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344(8934), 1383-1389 (1994).
2. Ridker PM, Danielson E, Fonseca FA et al.; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N. Engl. J. Med. 359(21), 2195-2207 (2008).
3. Nawawi H, Osman NS, Yusoff K, Khalid BA. Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia. Horm. Metab. Res. 35(8), 479-485 (2003).
4. Rezaie-Majd A, Maca T, Bucek RA et al. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol. 22(7), 1194-1199 (2002).
5. Fukumoto Y, Libby P, Rabkin E et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation 103(7), 993-999 (2001).
6. Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1,-2,-3, and-9 from vascular smooth muscle cells and macrophages. Arterioscler. Thromb. Vasc. Biol. 23(5), 769-775 (2003).
7. Massaro M, Zampolli A, Scoditti E et al. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. Cardiovasc. Res. 86(2), 311-320 (2010).
8. Sukhova GK, Williams JK, Libby P. Statins reduce infammation in atheroma of nonhuman primates independent of effects on serum cholesterol. Arterioscler. Thromb. Vasc. Biol. 22(9), 1452-1458 (2002).
9. Williams JK, Sukhova GK, Herrington DM, Libby P. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J. Am. Coll. Cardiol. 31(3), 684-691 (1998).
10. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, infammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103(7), 926-933 (2001).
11. Kadoglou NP, Sailer N, Moumtzouoglou A, Kapelouzou A, Gerasimidis T, Liapis CD. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. J. Vasc. Surg. 51(1), 114-121 (2010).
12. Underhill HR, Yuan C, Zhao XQ et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am. Heart J. 155(3), 584e581-e588 (2008).
13. Tang TY, Howarth SP, Miller SR et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J. Am. Coll. Cardiol. 53(22), 2039-2050 (2009).
14. Puato M, Faggin E, Rattazzi M et al. Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy. Stroke 41(6), 1163-1168 (2010).
15. Verhoeven BA, Moll FL, Koekkoek JA et al. Statin treatment is not associated with consistent alterations in infammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy. Stroke 37(8), 2054-2060 (2006).
16. Peeters W, Hellings WE, de Kleijn DP et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler. Thromb. Vasc. Biol. 29(1), 128-133 (2009).
17. Makris GC, Lavida A, Nicolaides AN, Geroulakos G. The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins? Atherosclerosis DOI: 10.1016/j. atherosclerosis.2010.04.032 (2010) (Epub ahead of print).